Oncogenic EP300 can be targeted with inhibitors of aldo-keto reductases

Autor: Mahmud, Zimam, Asaduzzaman, Muhammad, Kumar, Uttom, Masrour, Nahal, Jugov, Roman, Coombes, R. Charles, Shousha, Sami, Hu, Yunhui, Lam, Eric W.-F., Yagüe, Ernesto
Zdroj: In Biochemical Pharmacology May 2019 163:391-403
Databáze: ScienceDirect